Cargando…
Bacillus Calmette–Guerin Immunotherapy for Recurrent Multiple Warts: An Open-Label Uncontrolled Study
Autor principal: | Al-Mendalawi, Mahmood Dhahir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375523/ https://www.ncbi.nlm.nih.gov/pubmed/34446968 http://dx.doi.org/10.4103/ijd.IJD_199_19 |
Ejemplares similares
-
Bacillus Calmette–Guerin Immunotherapy for Recurrent Multiple Warts: An Open-Label Uncontrolled Study
por: Jaisinghani, Avtar Kishan, et al.
Publicado: (2019) -
Re: The Bacillus Calmette-Guerin (BCG) Vaccine: Is it a better choice for the treatment of viral warts?
por: Al-Mendalawi, Mahmood D.
Publicado: (2021) -
Excellent Response to Intralesional Bacillus Calmette-Guérin Vaccine in a Recalcitrant Periungual Wart
por: Kumar, Piyush, et al.
Publicado: (2014) -
The management of vulvovaginal warts using intralesional Bacillus Calmette–Guérin immunotherapy
por: Gupta, Sunil Kumar
Publicado: (2020) -
Tuberculous prostatic abscess following intravesical bacillus Calmette-Guérin immunotherapy
por: Wang, Bin, et al.
Publicado: (2019)